1H and 13C NMR spectra of antimicrobial 4-arylamino-3-nitrocoumarin derivatives
used as supplied, except the solvents, which were purified by
distillation.
2-[(3-nitro-2-oxo-2H-chromen-4-yl)amino]benzoic acid (3a,
C16H10N2O6)
Yellow crystals, yield 79%, mp 226–228 ◦C (Lit.[11] 227–228 ◦C).
HRMS(EI): M+ (C16H10N2O6) 326.0560, requires 326.0539 (ꢀ =
+2.1 mmu). IR (neat): 3420 (O–H, N–H), 1703 (C O), 1606 (C C),
NMR spectra
1553 and 1330 (NO2), 1289, 1032, 823, 782 cm−1. For 1H and 13
C
All NMR spectra were recorded at 25 ◦C in CDCl3 with TMS as
an internal standard. Chemical shifts are reported in ppm (δ) and
referenced to TMS (δH = 0 ppm) in 1H NMR spectra or to residual
CDCl3 (δH = 7.25 ppm, δC = 77 ppm) in heteronuclear 2D spectra.
Scalar couplings are reported in Hertz. Typically, 20–30 mg of
sample was dissolved in 1 ml of CDCl3, and 0.7 ml of the solution
transferred into a 5-mm Norell 507 NMR tube.
The1Hand13CNMRspectraofcompounds3a–gwererecorded
on a Bruker DMX 500 spectrometer operating at 500.26 and
125.8 MHz, respectively, equipped with a 5-mm dual 13C/1H probe
head. The 1H spectra were recorded with 16 scans, 1 s relaxation
delay, 4 s acquisition time, 0.125 Hz digital FID resolution, 51 280
FID size, with 6410 Hz spectral width, and an overall data point
resolution of 0.0003 ppm. The 13C spectra were recorded with
Waltz 161H broadband decoupling, 1024 scans, 0.5 s relaxation
delay, 1 s acquisition time, 0.5 Hz digital FID resolution, 65 536 FID
size, 31 850 Hz spectral width, and an overall data point resolution
of 0.005 ppm.
2D spectra were recorded on a Bruker DMX 500 spectrometer
(500.26 MHz for 1H, 125.8 MHz for 13C) equipped with an inverse
detection triple resonance 5-mm probe (TXI). Standard pulse
sequences were used for 2D spectra. COSY and NOESY spectra
were recorded at spectral widths of 5 kHz in both F2 and F1
domains; 1 K × 512 data points were acquired with 32 scans per
increment and the relaxation delays of 2.0 s. The mixing time
in NOESY experiments was 1 s. Data processing was performed
on a 1K × 1K data matrix. Inverse-detected 2D heteronuclear
correlated spectra were measured over 512 complex points in
F2 and 256 increments in F1, collecting 128 (HSQC) or 256
(HMBC) scans per increment with a relaxation delay of 1.0 s.
The spectral widths were 5 and 27 kHz in F2 and F1 dimensions,
respectively. The HSQC experiments were optimized for C–H
couplings of 145 Hz; the HMBC experiments were optimized
for long-range C–H couplings of 10 Hz. Fourier transforms were
performed on a 512 × 512 data matrix. π/2 Shifted sine-squared
window functions were used along F1 and F2 axes for all 2D
spectra.
NMR spectra, see Table 1. For NOESY, HMBC and HSQC spectra,
see Supporting information.
4-[(4ꢁ-amino-3,3ꢁ-dimethoxybiphenyl-4-yl)amino]-3-nitro-2H-
chromen-2-one (3b, C23H19N3O6)
Brown crystals, yield 72%, mp 215–218 ◦C. HRMS(EI): M+
(C23H19N3O6) 433.1285, requires 433.1274 (ꢀ = +1.1 mmu). IR
(neat): 3376–3039 (N–H and Ar–H), 2941 (C–H), 1702 (C O),
1608 (C C), 1537 and 1344 (NO2), 1224, 1032, 751, 690 cm−1. For
1H and 13C NMR spectra, see Table 1. For NOESY, HMBC and HSQC
spectra, see Supporting information.
4-[(4-aminophenyl)amino]-3-nitro-2H-chromen-2-one(3c,
C15H11N3O4)
Brown crystals, yield 84%, mp 228–230 ◦C. HRMS(EI): M+
(C15H11N3O4) 297.0743, requires 297.0750 (ꢀ = −0.7 mmu). IR
(neat): 3371–3068 (N–H and Ar–H), 1710 (C O), 1605 (C C),
1549 and 1332 (NO2), 1240, 1056, 945, 782, 756 cm−1. For 1H and
13C NMR spectra, see Tables 2 and 3.
3-nitro-4-[(3-nitrophenyl)amino]-2H-chromen-2-one(3d,
C
15H9N3O6)
Yellow crystals, yield 72%, mp 253–255 ◦C. HRMS(EI): M+
(C15H9N3O6) 327.0474, requires 327.0491 (ꢀ = −1.7 mmu). IR
(neat): 3348–3080 (N–H and Ar–H), 1689 (C O), 1606 (C C),
1548 and 1354 (NO2), 1266, 1064, 821, 761 cm−1. For 1H and 13
NMR spectra, see Tables 2 and 3.
C
4-[(4-methylphenyl)amino]-3-nitro-2H-chromen-2-one(3e,
C
16H12N2O4)
Yellow crystals, yield 70%, mp 192–194 ◦C (Lit.[12] 193–195 ◦C).
HRMS(EI): M+ (C16H12N2O4) 296.0815, requires 296.0797 (ꢀ =
+1.8 mmu). IR (neat), 3276–3072 (N–H and Ar–H), 2919 (CH3),
1693 (C O), 1610 (C C), 1548 and 1322 (NO2), 1208, 1054, 813,
757 cm−1. For 1H and 13C NMR spectra, see Tables 2 and 3.
Synthesis of 4-chloro-3-nitrocoumarin (1)
4-[(2-methylphenyl)amino]-3-nitro-2H-chromen-2-one(3f,
4-Hydroxycoumarin (Merck, Germany) was nitrated using 72%
HNO3 in glacial AcOH according to a published procedure,[12] to
afford 4-hydroxy-3-nitrocoumarin. The starting compound 1 was
prepared from 4-hydroxy-3-nitrocoumarin following the method
of Chechi et al.,[24] modified by Kaljaj et al.[25] Melting point, IR and
1H NMR spectral data were identical to those described.[24]
C
16H12N2O4)
Yellow crystals, yield 81%, mp 180–182 ◦C. HRMS(EI): M+
(C16H12N2O4) 296.0781, requires 296.0797 (ꢀ = −1.6 mmu). IR
(neat): 3120–3036 (N–H and Ar–H), 2947 (CH3), 1705 (C O), 1612
(C C), 1556 and 1323 (NO2), 1218, 1054, 798, 749 cm−1. For H
1
and 13C NMR spectra, see Tables 2 and 3.
General synthesis of 4-arylamino-3-nitrocoumarins (3a–g)
4-[(4-iodophenyl)amino]-3-nitro-2H-chromen-2-one (3g,
C
15H9IN2O4)
The solution of 4-chloro-3-nitrocoumarin (1 g, 4.4 mmol) and the
appropriate arylamine (2a–g) (4.4 mmol) in ethyl acetate (10 cm3)
in the presence of triethylamine (1 cm3, 7.2 mmol) was refluxed for
1–3 h. After cooling, the precipitated solid was filtered off, washed
with ethyl acetate and then water. The purity of the synthesized
compounds was assessed by TLC.
Yellow crystals, yield 76%, mp 250–253 ◦C. HRMS(EI): M+
(C15H9IN2O4) 407.9616, requires 407.9607 (ꢀ = +0.9 mmu). IR
(neat): 3286 (N–H), 1686 (C O), 1604 (C C), 1548 and 1334
(NO2), 1207, 1057, 843, 784 cm−1. For 1H and 13C NMR spectra, see
Tables 2 and 3.
c
Magn. Reson. Chem. 2010, 48, 896–902
Copyright ꢀ 2010 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/mrc